UBE2K and gastric cancer: Previous studies show that decreasing HIP2 expression may increase the risk of dopaminergic neuronal death and motor function impairment [49] and suppress the cell cycle, cell proliferation, cell migration, and wound healing in gastric cancer cells [50].